Rockefeller Capital Management L.P. Cuts Holdings in Chemed Co. (NYSE:CHE)

Rockefeller Capital Management L.P. lowered its position in Chemed Co. (NYSE:CHE - Free Report) by 39.9% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 24,557 shares of the company's stock after selling 16,292 shares during the period. Rockefeller Capital Management L.P. owned 0.16% of Chemed worth $13,018,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CHE. UMB Bank n.a. increased its holdings in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atala Financial Inc acquired a new stake in shares of Chemed in the 4th quarter worth $29,000. CBIZ Investment Advisory Services LLC increased its stake in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after acquiring an additional 22 shares during the last quarter. Trust Co. of Vermont purchased a new position in shares of Chemed during the 4th quarter worth $34,000. Finally, Tortoise Investment Management LLC grew its holdings in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after purchasing an additional 34 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Stock Performance

CHE traded down $0.86 during trading on Friday, hitting $580.52. The stock had a trading volume of 110,655 shares, compared to its average volume of 97,899. The firm has a market capitalization of $8.48 billion, a P/E ratio of 29.33, a PEG ratio of 2.15 and a beta of 0.49. The company's 50-day moving average price is $585.78 and its 200 day moving average price is $567.83. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $623.61.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed's payout ratio is 10.05%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada upped their price target on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a report on Friday, March 14th.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 3.32% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.